Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01891604
NCT01891604
Withdrawn
Not Applicable

Study the Safety and Efficacy of Probiotics Use in Premature Infants

University of Manitoba0 sitesJuly 3, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsInfant, Premature, Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infant, Premature, Diseases
Sponsor
University of Manitoba
Primary Endpoint
Calprotectin will be used to determine the effect for probiotics
Status
Withdrawn
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Prophylactic enteral probiotics may enhance clinical markers and biomarkers of preterm infants' health, and may also play a role in reducing NEC and associated morbidity.

Registry
clinicaltrials.gov
Start Date
July 3, 2013
End Date
December 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. James Friel

Professor

University of Manitoba

Eligibility Criteria

Inclusion Criteria

  • •born with weight\<1500 g
  • •hospitalized within 48 hours after birth

Exclusion Criteria

  • •present with evidence or suspicion of congenital intestinal obstruction
  • •perforation
  • •gastroschisis
  • •large omphalocele
  • •congenital diaphragmatic hernia
  • •major congenital heart defects

Outcomes

Primary Outcomes

Calprotectin will be used to determine the effect for probiotics

Time Frame: day1 and day30 of the observation

Similar Trials

Recruiting
Not Applicable
Probiotic Supplementation in Extremely Preterm Infants in ScandinaviaNecrotizing EnterocolitisDeathSepsis NewbornFeeding Disorder NeonatalGrowth Acceleration
NCT05604846Region Stockholm1,600
Completed
Not Applicable
Probiotics Supplementation in Premature InfantsPrematurity
NCT01379417Société des Produits Nestlé (SPN)199
Not yet recruiting
Not Applicable
Evaluation of the effect of probiotics in preventing low anterior resection syndromePatients with rectal cancer whose adenocarcinoma is pathologically proven and indicated for anterior resection..Malignant neoplasm of colon, unspecifiedC18.9
IRCT20210704051784N1Tehran University of Medical Sciences180
Completed
Not Applicable
Bifidobacterium Supplementation for Very Low Birth Weight InfantsPreterm Infants
NCT01375309Tokyo Women's Medical University246
Recruiting
Phase 2
Effects of probiotics on the prevalence of ventilator-associated pneumoniaVentilator-associated pneumonia.Ventilator associated pneumoniaJ95.851
IRCT20190325043107N18Tabriz University of Medical Sciences150